

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 8.36180577 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 8.36180577 |
| 3 | signal peptide processing (GO:0006465) | 6.87458093 |
| 4 | chromatin remodeling at centromere (GO:0031055) | 5.08158340 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.01562952 |
| 6 | establishment of integrated proviral latency (GO:0075713) | 4.99145042 |
| 7 | DNA double-strand break processing (GO:0000729) | 4.67375259 |
| 8 | DNA replication checkpoint (GO:0000076) | 4.55543396 |
| 9 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.55493310 |
| 10 | proteasome assembly (GO:0043248) | 4.55256839 |
| 11 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.50907567 |
| 12 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.47222680 |
| 13 | mitotic metaphase plate congression (GO:0007080) | 4.41181568 |
| 14 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.39200543 |
| 15 | protein localization to kinetochore (GO:0034501) | 4.36611316 |
| 16 | COPII vesicle coating (GO:0048208) | 4.30435060 |
| 17 | histone exchange (GO:0043486) | 4.26835728 |
| 18 | DNA strand elongation (GO:0022616) | 4.26437950 |
| 19 | ribosome assembly (GO:0042255) | 4.22773671 |
| 20 | protein retention in ER lumen (GO:0006621) | 4.19979291 |
| 21 | GMP metabolic process (GO:0046037) | 4.11915526 |
| 22 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.07873170 |
| 23 | metaphase plate congression (GO:0051310) | 4.03565761 |
| 24 | ER overload response (GO:0006983) | 4.02608072 |
| 25 | sequestering of metal ion (GO:0051238) | 4.01060741 |
| 26 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.00825388 |
| 27 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.96886489 |
| 28 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.96395304 |
| 29 | DNA replication-independent nucleosome organization (GO:0034724) | 3.96395304 |
| 30 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.94057314 |
| 31 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.94057314 |
| 32 | protein maturation by protein folding (GO:0022417) | 3.92119335 |
| 33 | telomere maintenance via recombination (GO:0000722) | 3.91097317 |
| 34 | mitotic recombination (GO:0006312) | 3.85584328 |
| 35 | retinal rod cell development (GO:0046548) | 3.85395827 |
| 36 | IMP biosynthetic process (GO:0006188) | 3.83872306 |
| 37 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.83456735 |
| 38 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.83126943 |
| 39 | negative regulation of ligase activity (GO:0051352) | 3.83126943 |
| 40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.81371368 |
| 41 | cullin deneddylation (GO:0010388) | 3.77825903 |
| 42 | purine nucleobase biosynthetic process (GO:0009113) | 3.75602059 |
| 43 | protein localization to chromosome, centromeric region (GO:0071459) | 3.71042572 |
| 44 | spindle checkpoint (GO:0031577) | 3.70320023 |
| 45 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.67962605 |
| 46 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.67962605 |
| 47 | regulation of penile erection (GO:0060405) | 3.65449635 |
| 48 | exocrine pancreas development (GO:0031017) | 3.64258393 |
| 49 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.63464711 |
| 50 | mitotic spindle checkpoint (GO:0071174) | 3.61257910 |
| 51 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.60291114 |
| 52 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.57712587 |
| 53 | negative regulation of sister chromatid segregation (GO:0033046) | 3.57712587 |
| 54 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.57712587 |
| 55 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.57712587 |
| 56 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.57712587 |
| 57 | vesicle coating (GO:0006901) | 3.53431137 |
| 58 | ATP synthesis coupled proton transport (GO:0015986) | 3.53220222 |
| 59 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.53220222 |
| 60 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.52935814 |
| 61 | negative regulation of chromosome segregation (GO:0051985) | 3.51051318 |
| 62 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.48629584 |
| 63 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.48629584 |
| 64 | non-recombinational repair (GO:0000726) | 3.47177700 |
| 65 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.47177700 |
| 66 | maturation of 5.8S rRNA (GO:0000460) | 3.45250854 |
| 67 | nucleobase biosynthetic process (GO:0046112) | 3.45050685 |
| 68 | peptide hormone processing (GO:0016486) | 3.44855376 |
| 69 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.43614277 |
| 70 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.43614277 |
| 71 | mitotic sister chromatid segregation (GO:0000070) | 3.42360675 |
| 72 | protein deneddylation (GO:0000338) | 3.42152334 |
| 73 | IMP metabolic process (GO:0046040) | 3.41898236 |
| 74 | kinetochore organization (GO:0051383) | 3.41486428 |
| 75 | replication fork processing (GO:0031297) | 3.41160489 |
| 76 | regulation of helicase activity (GO:0051095) | 3.41022859 |
| 77 | protein neddylation (GO:0045116) | 3.40735860 |
| 78 | regulation of centriole replication (GO:0046599) | 3.37978931 |
| 79 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.37338549 |
| 80 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.35861754 |
| 81 | isotype switching (GO:0045190) | 3.35861754 |
| 82 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.35861754 |
| 83 | response to X-ray (GO:0010165) | 3.35453861 |
| 84 | de novo posttranslational protein folding (GO:0051084) | 3.33589973 |
| 85 | mitotic spindle assembly checkpoint (GO:0007094) | 3.31558441 |
| 86 | telomere maintenance via telomere lengthening (GO:0010833) | 3.31410415 |
| 87 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.29624774 |
| 88 | establishment of chromosome localization (GO:0051303) | 3.29474271 |
| 89 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.29450780 |
| 90 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.29450780 |
| 91 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.29450780 |
| 92 | spindle assembly checkpoint (GO:0071173) | 3.29193834 |
| 93 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.28226531 |
| 94 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.28164375 |
| 95 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.28164375 |
| 96 | regulation of sister chromatid segregation (GO:0033045) | 3.28164375 |
| 97 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.27771635 |
| 98 | succinate metabolic process (GO:0006105) | 3.27292005 |
| 99 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.26451133 |
| 100 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.25731509 |
| 101 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.25606665 |
| 102 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.25606665 |
| 103 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.25505164 |
| 104 | toxin metabolic process (GO:0009404) | 3.25157112 |
| 105 | glycoside metabolic process (GO:0016137) | 3.24924852 |
| 106 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.23875307 |
| 107 | regulation of chromosome segregation (GO:0051983) | 3.23706570 |
| 108 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.23003409 |
| 109 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.23003409 |
| 110 | nuclear pore organization (GO:0006999) | 3.21726003 |
| 111 | sister chromatid segregation (GO:0000819) | 3.21549878 |
| 112 | de novo protein folding (GO:0006458) | 3.21138091 |
| 113 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.19220363 |
| 114 | nuclear pore complex assembly (GO:0051292) | 3.18381012 |
| 115 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.17431420 |
| 116 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.17431420 |
| 117 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.16857196 |
| 118 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.15723098 |
| 119 | glycerol ether metabolic process (GO:0006662) | 3.15338059 |
| 120 | protein-cofactor linkage (GO:0018065) | 3.14721557 |
| 121 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.14013564 |
| 122 | mitotic nuclear envelope disassembly (GO:0007077) | 3.13472074 |
| 123 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.13381004 |
| 124 | cell cycle G1/S phase transition (GO:0044843) | 3.13381004 |
| 125 | histone mRNA metabolic process (GO:0008334) | 3.13365092 |
| 126 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.12502463 |
| 127 | positive regulation of ligase activity (GO:0051351) | 3.12382130 |
| 128 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.11537317 |
| 129 | regulation of DNA endoreduplication (GO:0032875) | 3.10539800 |
| 130 | endocrine pancreas development (GO:0031018) | 3.09815125 |
| 131 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.07377122 |
| 132 | DNA unwinding involved in DNA replication (GO:0006268) | 3.05213916 |
| 133 | ether metabolic process (GO:0018904) | 3.05099743 |
| 134 | heme biosynthetic process (GO:0006783) | 3.04532508 |
| 135 | rRNA modification (GO:0000154) | 3.04287330 |
| 136 | tricarboxylic acid cycle (GO:0006099) | 3.02449871 |
| 137 | peptidyl-asparagine modification (GO:0018196) | 3.02332068 |
| 138 | fucose metabolic process (GO:0006004) | 3.01000017 |
| 139 | photoreceptor cell development (GO:0042461) | 2.93006663 |
| 140 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.90583611 |
| 141 | protein autoprocessing (GO:0016540) | 2.88832183 |
| 142 | purine ribonucleotide transport (GO:0015868) | 2.88653020 |
| 143 | protein complex biogenesis (GO:0070271) | 2.86823882 |
| 144 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.83327191 |
| 145 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.83253506 |
| 146 | * cell redox homeostasis (GO:0045454) | 2.82629308 |
| 147 | protein N-linked glycosylation (GO:0006487) | 2.80835582 |
| 148 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.79701054 |
| 149 | rhodopsin mediated signaling pathway (GO:0016056) | 2.78188740 |
| 150 | eye photoreceptor cell development (GO:0042462) | 2.76934728 |
| 151 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.76887126 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.76718550 |
| 153 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.75642086 |
| 154 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.75642086 |
| 155 | dopamine biosynthetic process (GO:0042416) | 2.75384498 |
| 156 | DNA topological change (GO:0006265) | 2.74043730 |
| 157 | CENP-A containing nucleosome assembly (GO:0034080) | 2.73820394 |
| 158 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.73277476 |
| 159 | intraciliary transport (GO:0042073) | 2.69981699 |
| 160 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.68693000 |
| 161 | purine-containing compound salvage (GO:0043101) | 2.66391101 |
| 162 | dopamine transport (GO:0015872) | 2.66173257 |
| 163 | viral mRNA export from host cell nucleus (GO:0046784) | 2.66111821 |
| 164 | daunorubicin metabolic process (GO:0044597) | 2.63972240 |
| 165 | polyketide metabolic process (GO:0030638) | 2.63972240 |
| 166 | doxorubicin metabolic process (GO:0044598) | 2.63972240 |
| 167 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.63940963 |
| 168 | NADH dehydrogenase complex assembly (GO:0010257) | 2.63940963 |
| 169 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.63940963 |
| 170 | respiratory electron transport chain (GO:0022904) | 2.63707543 |
| 171 | negative regulation of norepinephrine secretion (GO:0010700) | 2.62644634 |
| 172 | nucleotide transmembrane transport (GO:1901679) | 2.61121021 |
| 173 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.60801535 |
| 174 | electron transport chain (GO:0022900) | 2.60106465 |
| 175 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.57386333 |
| 176 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.56203155 |
| 177 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.55437437 |
| 178 | regulation of metalloenzyme activity (GO:0048552) | 2.54940897 |
| 179 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.53221648 |
| 180 | heme metabolic process (GO:0042168) | 2.51595592 |
| 181 | DNA ligation (GO:0006266) | 2.51360938 |
| 182 | negative regulation of B cell mediated immunity (GO:0002713) | 2.50716626 |
| 183 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.50716626 |
| 184 | establishment of viral latency (GO:0019043) | 2.50042915 |
| 185 | catechol-containing compound biosynthetic process (GO:0009713) | 2.49489022 |
| 186 | catecholamine biosynthetic process (GO:0042423) | 2.49489022 |
| 187 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.49250184 |
| 188 | positive regulation of insulin secretion (GO:0032024) | 2.48511015 |
| 189 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.48034116 |
| 190 | detection of light stimulus involved in visual perception (GO:0050908) | 2.48034116 |
| 191 | multicellular organismal aging (GO:0010259) | 2.46391477 |
| 192 | chaperone-mediated protein folding (GO:0061077) | 2.45143769 |
| 193 | * protein folding (GO:0006457) | 2.44277019 |
| 194 | catecholamine transport (GO:0051937) | 2.44219213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.71121240 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.31771080 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.68934552 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.67804984 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.59502067 |
| 6 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.14177611 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.10467137 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.06969738 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.05409706 |
| 10 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.90160139 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.89827478 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.83711890 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.80409807 |
| 14 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.67373684 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.50516549 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.46652515 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.46351793 |
| 18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.43519646 |
| 19 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.40878462 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.33162335 |
| 21 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.31431276 |
| 22 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.29654029 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.28628482 |
| 24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.19240904 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.16955473 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15859508 |
| 27 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.10057061 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.05571684 |
| 29 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.05118892 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.04276259 |
| 31 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.00442157 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98141876 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.94997480 |
| 34 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92549037 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89376618 |
| 36 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.89057620 |
| 37 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.89044438 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.80454158 |
| 39 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.68730047 |
| 40 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65299992 |
| 41 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.65176317 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.64840095 |
| 43 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63330741 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63213215 |
| 45 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.62541930 |
| 46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60434679 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.57528006 |
| 48 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.56210984 |
| 49 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.55508584 |
| 50 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.55478571 |
| 51 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54491051 |
| 52 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.54082735 |
| 53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.53623799 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52091075 |
| 55 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51631354 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.49528912 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49418122 |
| 58 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.48116577 |
| 59 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.43618249 |
| 60 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42128126 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40789809 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39120209 |
| 63 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.39099061 |
| 64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.37123124 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.34484602 |
| 66 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.33192914 |
| 67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33121322 |
| 68 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33064537 |
| 69 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33012886 |
| 70 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.32243639 |
| 71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29882497 |
| 72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29292568 |
| 73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.28347315 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26704145 |
| 75 | EWS_26573619_Chip-Seq_HEK293_Human | 1.25608512 |
| 76 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24729457 |
| 77 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.24423643 |
| 78 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.23110567 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22821218 |
| 80 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.22581974 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21442825 |
| 82 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.21125222 |
| 83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20184177 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19775035 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17898682 |
| 86 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.16300927 |
| 87 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.15327413 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14906992 |
| 89 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14450544 |
| 90 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.11791235 |
| 91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.11660210 |
| 92 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.10970957 |
| 93 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.10511174 |
| 94 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09974468 |
| 95 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08824414 |
| 96 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08706152 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.06794380 |
| 98 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.05641291 |
| 99 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.05387396 |
| 100 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05384464 |
| 101 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03698332 |
| 102 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03545325 |
| 103 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01007057 |
| 104 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00854645 |
| 105 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00524756 |
| 106 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.00311466 |
| 107 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99729525 |
| 108 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99473900 |
| 109 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98858402 |
| 110 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97125697 |
| 111 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96938988 |
| 112 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94920995 |
| 113 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94780333 |
| 114 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93289100 |
| 115 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.93246549 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91354460 |
| 117 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91212087 |
| 118 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89268940 |
| 119 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89074409 |
| 120 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88880727 |
| 121 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.88712550 |
| 122 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87082988 |
| 123 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.85856730 |
| 124 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.84200969 |
| 125 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84150193 |
| 126 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82405157 |
| 127 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.82297930 |
| 128 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.82038707 |
| 129 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81660129 |
| 130 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78635941 |
| 131 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.74160962 |
| 132 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.71467150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010094_abnormal_chromosome_stability | 5.11425753 |
| 2 | MP0008057_abnormal_DNA_replication | 4.68791110 |
| 3 | MP0006054_spinal_hemorrhage | 4.45271924 |
| 4 | MP0003693_abnormal_embryo_hatching | 4.39666539 |
| 5 | MP0003183_abnormal_peptide_metabolism | 4.30863566 |
| 6 | MP0008058_abnormal_DNA_repair | 4.19533437 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.84547207 |
| 8 | MP0006072_abnormal_retinal_apoptosis | 3.74597295 |
| 9 | MP0000013_abnormal_adipose_tissue | 3.38092196 |
| 10 | MP0003122_maternal_imprinting | 3.34768457 |
| 11 | MP0003077_abnormal_cell_cycle | 3.24184374 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 3.07637050 |
| 13 | MP0005551_abnormal_eye_electrophysiolog | 2.95754738 |
| 14 | MP0008932_abnormal_embryonic_tissue | 2.92175934 |
| 15 | MP0003941_abnormal_skin_development | 2.78733746 |
| 16 | MP0010386_abnormal_urinary_bladder | 2.74432577 |
| 17 | MP0003718_maternal_effect | 2.70252696 |
| 18 | MP0001529_abnormal_vocalization | 2.69561452 |
| 19 | MP0004147_increased_porphyrin_level | 2.68004629 |
| 20 | MP0005253_abnormal_eye_physiology | 2.60843588 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.59724155 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.47408258 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 2.40496676 |
| 24 | MP0003786_premature_aging | 2.24805315 |
| 25 | MP0005220_abnormal_exocrine_pancreas | 2.24213557 |
| 26 | MP0002638_abnormal_pupillary_reflex | 2.16593366 |
| 27 | MP0003195_calcinosis | 2.12993841 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 2.09406354 |
| 29 | MP0002090_abnormal_vision | 2.07949432 |
| 30 | MP0002909_abnormal_adrenal_gland | 2.03849424 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.98472162 |
| 32 | MP0005379_endocrine/exocrine_gland_phen | 1.94548103 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.87376029 |
| 34 | MP0004043_abnormal_pH_regulation | 1.86183282 |
| 35 | MP0001293_anophthalmia | 1.82421113 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.80377242 |
| 37 | MP0002693_abnormal_pancreas_physiology | 1.76254869 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.74860575 |
| 39 | MP0003121_genomic_imprinting | 1.70073956 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.69719139 |
| 41 | MP0003011_delayed_dark_adaptation | 1.69334271 |
| 42 | MP0003186_abnormal_redox_activity | 1.66535229 |
| 43 | MP0006292_abnormal_olfactory_placode | 1.65667187 |
| 44 | MP0002102_abnormal_ear_morphology | 1.64769791 |
| 45 | MP0001730_embryonic_growth_arrest | 1.64104845 |
| 46 | MP0010307_abnormal_tumor_latency | 1.62734323 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 1.61767533 |
| 48 | MP0005408_hypopigmentation | 1.60762481 |
| 49 | MP0001764_abnormal_homeostasis | 1.59505032 |
| 50 | MP0003567_abnormal_fetal_cardiomyocyte | 1.51703218 |
| 51 | MP0000350_abnormal_cell_proliferation | 1.50133920 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.48380009 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.47656263 |
| 54 | MP0009697_abnormal_copulation | 1.45708284 |
| 55 | MP0003724_increased_susceptibility_to | 1.45545730 |
| 56 | MP0005503_abnormal_tendon_morphology | 1.45314800 |
| 57 | MP0002933_joint_inflammation | 1.45064341 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.44525613 |
| 59 | MP0002254_reproductive_system_inflammat | 1.44140163 |
| 60 | MP0006035_abnormal_mitochondrial_morpho | 1.43907561 |
| 61 | MP0003937_abnormal_limbs/digits/tail_de | 1.43268417 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.43061021 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.41601369 |
| 64 | MP0001324_abnormal_eye_pigmentation | 1.39110140 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.36464898 |
| 66 | MP0008789_abnormal_olfactory_epithelium | 1.35701531 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 1.35607960 |
| 68 | MP0004215_abnormal_myocardial_fiber | 1.35277188 |
| 69 | MP0001697_abnormal_embryo_size | 1.33624578 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.30953442 |
| 71 | MP0003283_abnormal_digestive_organ | 1.30678219 |
| 72 | MP0002163_abnormal_gland_morphology | 1.30288867 |
| 73 | MP0000647_abnormal_sebaceous_gland | 1.29931254 |
| 74 | MP0003123_paternal_imprinting | 1.29761579 |
| 75 | MP0002928_abnormal_bile_duct | 1.24854037 |
| 76 | MP0003959_abnormal_lean_body | 1.23910364 |
| 77 | MP0005380_embryogenesis_phenotype | 1.23862596 |
| 78 | MP0001672_abnormal_embryogenesis/_devel | 1.23862596 |
| 79 | MP0003890_abnormal_embryonic-extraembry | 1.22571819 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.22160420 |
| 81 | MP0005195_abnormal_posterior_eye | 1.21993586 |
| 82 | MP0010678_abnormal_skin_adnexa | 1.21410845 |
| 83 | MP0002751_abnormal_autonomic_nervous | 1.19298695 |
| 84 | MP0001542_abnormal_bone_strength | 1.16864184 |
| 85 | MP0001299_abnormal_eye_distance/ | 1.15530823 |
| 86 | MP0002084_abnormal_developmental_patter | 1.15071556 |
| 87 | MP0002085_abnormal_embryonic_tissue | 1.08645645 |
| 88 | MP0008007_abnormal_cellular_replicative | 1.08616840 |
| 89 | MP0005391_vision/eye_phenotype | 1.08517024 |
| 90 | MP0009672_abnormal_birth_weight | 1.08164962 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 1.06965787 |
| 92 | MP0002080_prenatal_lethality | 1.06271154 |
| 93 | MP0004197_abnormal_fetal_growth/weight/ | 1.05512836 |
| 94 | MP0008004_abnormal_stomach_pH | 1.03164107 |
| 95 | MP0001286_abnormal_eye_development | 1.00613980 |
| 96 | MP0000313_abnormal_cell_death | 0.99245175 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.99203705 |
| 98 | MP0003984_embryonic_growth_retardation | 0.97904382 |
| 99 | MP0000383_abnormal_hair_follicle | 0.96906905 |
| 100 | MP0002111_abnormal_tail_morphology | 0.96301874 |
| 101 | MP0004233_abnormal_muscle_weight | 0.96252856 |
| 102 | MP0002088_abnormal_embryonic_growth/wei | 0.96107712 |
| 103 | MP0001502_abnormal_circadian_rhythm | 0.94644712 |
| 104 | MP0005646_abnormal_pituitary_gland | 0.94206898 |
| 105 | MP0005395_other_phenotype | 0.93204066 |
| 106 | MP0001929_abnormal_gametogenesis | 0.93041300 |
| 107 | MP0002210_abnormal_sex_determination | 0.92159081 |
| 108 | MP0000427_abnormal_hair_cycle | 0.91997889 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.90047096 |
| 110 | MP0002233_abnormal_nose_morphology | 0.89301412 |
| 111 | MP0004134_abnormal_chest_morphology | 0.88772525 |
| 112 | MP0002006_tumorigenesis | 0.87129214 |
| 113 | MP0002697_abnormal_eye_size | 0.84797154 |
| 114 | MP0003868_abnormal_feces_composition | 0.84008135 |
| 115 | MP0001145_abnormal_male_reproductive | 0.83891868 |
| 116 | MP0000681_abnormal_thyroid_gland | 0.83862808 |
| 117 | MP0001270_distended_abdomen | 0.83594787 |
| 118 | MP0002019_abnormal_tumor_incidence | 0.83547348 |
| 119 | MP0000516_abnormal_urinary_system | 0.83355163 |
| 120 | MP0005367_renal/urinary_system_phenotyp | 0.83355163 |
| 121 | MP0000653_abnormal_sex_gland | 0.82564112 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.81859687 |
| 123 | MP0004272_abnormal_basement_membrane | 0.81660893 |
| 124 | MP0001188_hyperpigmentation | 0.81331213 |
| 125 | MP0001119_abnormal_female_reproductive | 0.80679199 |
| 126 | MP0002396_abnormal_hematopoietic_system | 0.80494433 |
| 127 | MP0002160_abnormal_reproductive_system | 0.80173626 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.79599277 |
| 129 | MP0002796_impaired_skin_barrier | 0.79580150 |
| 130 | MP0001664_abnormal_digestion | 0.78832956 |
| 131 | MP0005394_taste/olfaction_phenotype | 0.78567096 |
| 132 | MP0005499_abnormal_olfactory_system | 0.78567096 |
| 133 | MP0003787_abnormal_imprinting | 0.78338125 |
| 134 | MP0002234_abnormal_pharynx_morphology | 0.78063406 |
| 135 | MP0003119_abnormal_digestive_system | 0.76216355 |
| 136 | MP0003795_abnormal_bone_structure | 0.75733020 |
| 137 | MP0002938_white_spotting | 0.75620657 |
| 138 | MP0002086_abnormal_extraembryonic_tissu | 0.73783808 |
| 139 | MP0005197_abnormal_uvea_morphology | 0.73433218 |
| 140 | MP0005501_abnormal_skin_physiology | 0.73266235 |
| 141 | MP0001243_abnormal_dermal_layer | 0.72715699 |
| 142 | MP0004084_abnormal_cardiac_muscle | 0.72614461 |
| 143 | MP0003300_gastrointestinal_ulcer | 0.72332682 |
| 144 | MP0002229_neurodegeneration | 0.71694735 |
| 145 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71113730 |
| 146 | MP0009703_decreased_birth_body | 0.70296134 |
| 147 | MP0005389_reproductive_system_phenotype | 0.70265542 |
| 148 | MP0001177_atelectasis | 0.69473007 |
| 149 | MP0001905_abnormal_dopamine_level | 0.68738092 |
| 150 | MP0005464_abnormal_platelet_physiology | 0.67053576 |
| 151 | MP0002009_preneoplasia | 0.66944089 |
| 152 | MP0001879_abnormal_lymphatic_vessel | 0.66340713 |
| 153 | MP0001853_heart_inflammation | 0.66250505 |
| 154 | MP0010368_abnormal_lymphatic_system | 0.65926744 |
| 155 | MP0010030_abnormal_orbit_morphology | 0.65507515 |
| 156 | MP0000579_abnormal_nail_morphology | 0.65155752 |
| 157 | MP0002282_abnormal_trachea_morphology | 0.64724017 |
| 158 | MP0002166_altered_tumor_susceptibility | 0.64658578 |
| 159 | MP0000163_abnormal_cartilage_morphology | 0.64376523 |
| 160 | MP0001533_abnormal_skeleton_physiology | 0.63708931 |
| 161 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63500104 |
| 162 | MP0009643_abnormal_urine_homeostasis | 0.63317999 |
| 163 | MP0001191_abnormal_skin_condition | 0.61963511 |
| 164 | MP0004782_abnormal_surfactant_physiolog | 0.60990080 |
| 165 | MP0000358_abnormal_cell_content/ | 0.60878893 |
| 166 | MP0004957_abnormal_blastocyst_morpholog | 0.60593814 |
| 167 | MP0001984_abnormal_olfaction | 0.59924185 |
| 168 | MP0000372_irregular_coat_pigmentation | 0.58831640 |
| 169 | MP0005083_abnormal_biliary_tract | 0.58240877 |
| 170 | MP0002139_abnormal_hepatobiliary_system | 0.53523457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.55960862 |
| 2 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.18818566 |
| 3 | Hypothermia (HP:0002045) | 4.11419154 |
| 4 | Congenital stationary night blindness (HP:0007642) | 4.03848305 |
| 5 | Neuroendocrine neoplasm (HP:0100634) | 4.03843691 |
| 6 | Chromsome breakage (HP:0040012) | 3.95149256 |
| 7 | Colon cancer (HP:0003003) | 3.81424729 |
| 8 | Abnormality of chromosome stability (HP:0003220) | 3.79823229 |
| 9 | Meckel diverticulum (HP:0002245) | 3.77694458 |
| 10 | Pheochromocytoma (HP:0002666) | 3.74320648 |
| 11 | Abnormality of the ileum (HP:0001549) | 3.58987323 |
| 12 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.56749169 |
| 13 | Abnormality of the preputium (HP:0100587) | 3.44856501 |
| 14 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.39861898 |
| 15 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.22187266 |
| 16 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.20590447 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.13440456 |
| 18 | Central scotoma (HP:0000603) | 3.13051545 |
| 19 | Abnormality of the labia minora (HP:0012880) | 3.11598235 |
| 20 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.02745705 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 2.99661904 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.96032433 |
| 23 | Small intestinal stenosis (HP:0012848) | 2.95765893 |
| 24 | Duodenal stenosis (HP:0100867) | 2.95765893 |
| 25 | Abnormal lung lobation (HP:0002101) | 2.95629903 |
| 26 | Acute necrotizing encephalopathy (HP:0006965) | 2.95045483 |
| 27 | Irregular epiphyses (HP:0010582) | 2.91386765 |
| 28 | Mitochondrial inheritance (HP:0001427) | 2.89275060 |
| 29 | Severe visual impairment (HP:0001141) | 2.80378804 |
| 30 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.78845144 |
| 31 | Hypoglycemic seizures (HP:0002173) | 2.77954176 |
| 32 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.74964306 |
| 33 | Birth length less than 3rd percentile (HP:0003561) | 2.73715298 |
| 34 | Vitreoretinal degeneration (HP:0000655) | 2.72942676 |
| 35 | Abnormality of the duodenum (HP:0002246) | 2.71041365 |
| 36 | Increased serum pyruvate (HP:0003542) | 2.70925348 |
| 37 | Abnormality of glycolysis (HP:0004366) | 2.70925348 |
| 38 | Embryonal renal neoplasm (HP:0011794) | 2.70341856 |
| 39 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.64076825 |
| 40 | Methylmalonic acidemia (HP:0002912) | 2.60474706 |
| 41 | Hepatic necrosis (HP:0002605) | 2.60051910 |
| 42 | Type I transferrin isoform profile (HP:0003642) | 2.59261757 |
| 43 | Symptomatic seizures (HP:0011145) | 2.58729273 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 2.58142092 |
| 45 | Abnormality of macular pigmentation (HP:0008002) | 2.54618791 |
| 46 | Hepatocellular necrosis (HP:0001404) | 2.54417081 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52595751 |
| 48 | Beaking of vertebral bodies (HP:0004568) | 2.52579673 |
| 49 | Increased CSF lactate (HP:0002490) | 2.51500643 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.51278929 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.49711275 |
| 52 | Congenital primary aphakia (HP:0007707) | 2.49042194 |
| 53 | Lipid accumulation in hepatocytes (HP:0006561) | 2.47460488 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.46920352 |
| 55 | Progressive macrocephaly (HP:0004481) | 2.46730868 |
| 56 | Gait imbalance (HP:0002141) | 2.46541875 |
| 57 | Rhabdomyosarcoma (HP:0002859) | 2.45109950 |
| 58 | Chorioretinal atrophy (HP:0000533) | 2.45109520 |
| 59 | Ketoacidosis (HP:0001993) | 2.44877805 |
| 60 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.44277010 |
| 61 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.44277010 |
| 62 | Abnormal protein glycosylation (HP:0012346) | 2.42646259 |
| 63 | Abnormal glycosylation (HP:0012345) | 2.42646259 |
| 64 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.42646259 |
| 65 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.42646259 |
| 66 | Cervical subluxation (HP:0003308) | 2.40159809 |
| 67 | Retinal atrophy (HP:0001105) | 2.39413756 |
| 68 | Ependymoma (HP:0002888) | 2.39162286 |
| 69 | Volvulus (HP:0002580) | 2.37248256 |
| 70 | Neoplasm of the adrenal gland (HP:0100631) | 2.36664322 |
| 71 | Medulloblastoma (HP:0002885) | 2.36116687 |
| 72 | Abnormality of the anterior horn cell (HP:0006802) | 2.35596471 |
| 73 | Degeneration of anterior horn cells (HP:0002398) | 2.35596471 |
| 74 | Increased hepatocellular lipid droplets (HP:0006565) | 2.35379731 |
| 75 | Neoplasm of the colon (HP:0100273) | 2.35158534 |
| 76 | Sloping forehead (HP:0000340) | 2.33774737 |
| 77 | Abnormality of serum amino acid levels (HP:0003112) | 2.32054716 |
| 78 | Irregular vertebral endplates (HP:0003301) | 2.31834861 |
| 79 | Clubbing of toes (HP:0100760) | 2.31355563 |
| 80 | Myelodysplasia (HP:0002863) | 2.29570543 |
| 81 | Menstrual irregularities (HP:0000858) | 2.29518557 |
| 82 | Epiphyseal dysplasia (HP:0002656) | 2.24294030 |
| 83 | Acute encephalopathy (HP:0006846) | 2.24034345 |
| 84 | Papilledema (HP:0001085) | 2.23863815 |
| 85 | Cerebral edema (HP:0002181) | 2.23286380 |
| 86 | 11 pairs of ribs (HP:0000878) | 2.22464236 |
| 87 | Nephrogenic diabetes insipidus (HP:0009806) | 2.19333914 |
| 88 | Neoplasm of head and neck (HP:0012288) | 2.18462559 |
| 89 | Esophageal neoplasm (HP:0100751) | 2.18462559 |
| 90 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.18336678 |
| 91 | Type II diabetes mellitus (HP:0005978) | 2.16975344 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15467955 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.15467955 |
| 94 | Palpitations (HP:0001962) | 2.14056180 |
| 95 | Flat capital femoral epiphysis (HP:0003370) | 2.12395627 |
| 96 | Methylmalonic aciduria (HP:0012120) | 2.12268888 |
| 97 | Exertional dyspnea (HP:0002875) | 2.12165541 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.10716477 |
| 99 | Scotoma (HP:0000575) | 2.10181187 |
| 100 | Triphalangeal thumb (HP:0001199) | 2.09708189 |
| 101 | Breast carcinoma (HP:0003002) | 2.09561234 |
| 102 | Intestinal atresia (HP:0011100) | 2.08917227 |
| 103 | Renal Fanconi syndrome (HP:0001994) | 2.08645809 |
| 104 | Increased serum lactate (HP:0002151) | 2.08416446 |
| 105 | Abnormal hair whorl (HP:0010721) | 2.08360673 |
| 106 | Glioma (HP:0009733) | 2.07356642 |
| 107 | Abnormality of the carotid arteries (HP:0005344) | 2.07021832 |
| 108 | Congenital, generalized hypertrichosis (HP:0004540) | 2.05801273 |
| 109 | Constricted visual fields (HP:0001133) | 2.05427631 |
| 110 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.04739634 |
| 111 | Horseshoe kidney (HP:0000085) | 2.04069287 |
| 112 | Pancytopenia (HP:0001876) | 2.03211020 |
| 113 | Reduced antithrombin III activity (HP:0001976) | 2.03064959 |
| 114 | Ovarian neoplasm (HP:0100615) | 2.02041679 |
| 115 | Microvesicular hepatic steatosis (HP:0001414) | 2.01871301 |
| 116 | Prominent metopic ridge (HP:0005487) | 2.01852105 |
| 117 | Abnormal pupillary function (HP:0007686) | 2.00979591 |
| 118 | Abolished electroretinogram (ERG) (HP:0000550) | 1.99633028 |
| 119 | Abnormality of the vertebral endplates (HP:0005106) | 1.98723536 |
| 120 | Hyperglycinemia (HP:0002154) | 1.98399063 |
| 121 | Ectopic kidney (HP:0000086) | 1.97602358 |
| 122 | Supernumerary spleens (HP:0009799) | 1.96928559 |
| 123 | Agnosia (HP:0010524) | 1.96161619 |
| 124 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.95906065 |
| 125 | Abnormality of alanine metabolism (HP:0010916) | 1.95906065 |
| 126 | Hyperalaninemia (HP:0003348) | 1.95906065 |
| 127 | Optic disc pallor (HP:0000543) | 1.95666189 |
| 128 | Biliary tract neoplasm (HP:0100574) | 1.95383897 |
| 129 | Retinitis pigmentosa (HP:0000510) | 1.91044716 |
| 130 | Agitation (HP:0000713) | 1.89164615 |
| 131 | Abnormality of the metopic suture (HP:0005556) | 1.88143772 |
| 132 | Spinal cord compression (HP:0002176) | 1.87690132 |
| 133 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.86657557 |
| 134 | Epiphyseal stippling (HP:0010655) | 1.85749400 |
| 135 | Absent radius (HP:0003974) | 1.84287239 |
| 136 | Abnormality of glycine metabolism (HP:0010895) | 1.83566550 |
| 137 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.83566550 |
| 138 | Uterine neoplasm (HP:0010784) | 1.83459304 |
| 139 | Abnormal gallbladder morphology (HP:0012437) | 1.83130436 |
| 140 | Multiple enchondromatosis (HP:0005701) | 1.82597443 |
| 141 | Hyperphosphaturia (HP:0003109) | 1.82410023 |
| 142 | Spastic diplegia (HP:0001264) | 1.82058455 |
| 143 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.81917003 |
| 144 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.81872921 |
| 145 | Median cleft lip (HP:0000161) | 1.81549541 |
| 146 | Increased intramyocellular lipid droplets (HP:0012240) | 1.81207507 |
| 147 | Lactic acidosis (HP:0003128) | 1.80760866 |
| 148 | Megaloblastic anemia (HP:0001889) | 1.79288067 |
| 149 | Pendular nystagmus (HP:0012043) | 1.78313816 |
| 150 | Aplastic anemia (HP:0001915) | 1.77865633 |
| 151 | Absent thumb (HP:0009777) | 1.77443260 |
| 152 | Protuberant abdomen (HP:0001538) | 1.77040347 |
| 153 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.76493715 |
| 154 | Postnatal microcephaly (HP:0005484) | 1.76342079 |
| 155 | Osteomalacia (HP:0002749) | 1.74869327 |
| 156 | Abnormal epiphyseal ossification (HP:0010656) | 1.73951155 |
| 157 | Neoplasm of the adrenal cortex (HP:0100641) | 1.73595017 |
| 158 | Respiratory failure (HP:0002878) | 1.73318492 |
| 159 | Absent forearm bone (HP:0003953) | 1.73257294 |
| 160 | Aplasia involving forearm bones (HP:0009822) | 1.73257294 |
| 161 | Abnormality of the pons (HP:0007361) | 1.72301960 |
| 162 | Increased cerebral lipofuscin (HP:0011813) | 1.70953253 |
| 163 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.70293202 |
| 164 | Absent epiphyses (HP:0010577) | 1.70293202 |
| 165 | Pigmentary retinal degeneration (HP:0001146) | 1.69961688 |
| 166 | Conjunctival hamartoma (HP:0100780) | 1.69354719 |
| 167 | Hyperbilirubinemia (HP:0002904) | 1.69293547 |
| 168 | Neoplasm of the small intestine (HP:0100833) | 1.68953224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRSK2 | 4.73860977 |
| 2 | PASK | 3.14981835 |
| 3 | SCYL2 | 2.93374106 |
| 4 | VRK2 | 2.83220194 |
| 5 | TTK | 2.72758308 |
| 6 | EIF2AK1 | 2.60365570 |
| 7 | TRIM28 | 2.54067225 |
| 8 | ERBB3 | 2.48544407 |
| 9 | MKNK2 | 2.45886510 |
| 10 | CAMKK2 | 2.45885185 |
| 11 | INSRR | 2.42840568 |
| 12 | PBK | 2.36679870 |
| 13 | PLK4 | 2.29735598 |
| 14 | ZAK | 2.28664411 |
| 15 | STK16 | 2.26942811 |
| 16 | PIK3CG | 2.24148318 |
| 17 | BMPR1B | 2.23498774 |
| 18 | TAOK3 | 2.16446536 |
| 19 | FLT3 | 2.13716772 |
| 20 | BRSK1 | 2.12759935 |
| 21 | BUB1 | 2.04853396 |
| 22 | TAF1 | 1.98409304 |
| 23 | EIF2AK3 | 1.94660971 |
| 24 | CCNB1 | 1.89934294 |
| 25 | WNK3 | 1.88343688 |
| 26 | TLK1 | 1.82548692 |
| 27 | NEK1 | 1.61602385 |
| 28 | CASK | 1.59534766 |
| 29 | MAPK15 | 1.57219153 |
| 30 | LIMK1 | 1.56965900 |
| 31 | TSSK6 | 1.55129931 |
| 32 | TEC | 1.54275947 |
| 33 | NME1 | 1.53770502 |
| 34 | CDC7 | 1.52103059 |
| 35 | TNIK | 1.47323738 |
| 36 | MST4 | 1.31663119 |
| 37 | PLK3 | 1.27300802 |
| 38 | VRK1 | 1.26433346 |
| 39 | YES1 | 1.25264469 |
| 40 | UHMK1 | 1.20356969 |
| 41 | FRK | 1.17969828 |
| 42 | NEK9 | 1.11418823 |
| 43 | STK3 | 1.09464449 |
| 44 | WEE1 | 1.09058620 |
| 45 | ACVR1B | 1.07528077 |
| 46 | SRPK1 | 1.06456915 |
| 47 | PLK2 | 1.03458769 |
| 48 | TGFBR1 | 1.02572296 |
| 49 | MAP4K2 | 1.00911242 |
| 50 | CSNK1G3 | 1.00364764 |
| 51 | HIPK2 | 0.98150345 |
| 52 | CHEK2 | 0.96636748 |
| 53 | GRK7 | 0.96410105 |
| 54 | ADRBK2 | 0.92555503 |
| 55 | ADRBK1 | 0.87243021 |
| 56 | IRAK4 | 0.87215856 |
| 57 | STK38L | 0.83730324 |
| 58 | MAP2K7 | 0.80691768 |
| 59 | DYRK1B | 0.80025050 |
| 60 | ERBB4 | 0.79321090 |
| 61 | PNCK | 0.78833218 |
| 62 | KIT | 0.78785516 |
| 63 | MKNK1 | 0.78566589 |
| 64 | PAK4 | 0.77753106 |
| 65 | STK4 | 0.77679800 |
| 66 | TESK2 | 0.76276497 |
| 67 | RPS6KA4 | 0.76223921 |
| 68 | MAPKAPK5 | 0.74874980 |
| 69 | NUAK1 | 0.74310400 |
| 70 | CDK8 | 0.73881990 |
| 71 | ATM | 0.71435361 |
| 72 | TBK1 | 0.71184656 |
| 73 | MAP3K12 | 0.70699844 |
| 74 | WNK4 | 0.70021951 |
| 75 | MARK3 | 0.69096124 |
| 76 | NME2 | 0.68881188 |
| 77 | BCR | 0.67205192 |
| 78 | STK24 | 0.66567813 |
| 79 | IRAK1 | 0.64236688 |
| 80 | STK10 | 0.63989212 |
| 81 | CSNK1G2 | 0.61254389 |
| 82 | BCKDK | 0.60211378 |
| 83 | CHEK1 | 0.60136831 |
| 84 | FGFR1 | 0.58846020 |
| 85 | TRPM7 | 0.57013223 |
| 86 | PAK3 | 0.56565298 |
| 87 | TESK1 | 0.54823126 |
| 88 | CDK6 | 0.53856775 |
| 89 | ITK | 0.53201065 |
| 90 | RPS6KA5 | 0.53120527 |
| 91 | CDK7 | 0.51000124 |
| 92 | CLK1 | 0.50381193 |
| 93 | ALK | 0.49361646 |
| 94 | CSNK2A1 | 0.48876986 |
| 95 | DAPK1 | 0.48410175 |
| 96 | DYRK2 | 0.48107166 |
| 97 | ZAP70 | 0.48034774 |
| 98 | CSNK1G1 | 0.46264653 |
| 99 | DYRK3 | 0.45799080 |
| 100 | PRKCE | 0.45533053 |
| 101 | LYN | 0.45054014 |
| 102 | PIM2 | 0.44709840 |
| 103 | CDK14 | 0.44460086 |
| 104 | * CSNK2A2 | 0.43510518 |
| 105 | MAPK13 | 0.43081780 |
| 106 | MYLK | 0.43049437 |
| 107 | PDK2 | 0.42166439 |
| 108 | DYRK1A | 0.41259041 |
| 109 | AURKB | 0.41233827 |
| 110 | BRAF | 0.41003204 |
| 111 | CAMK2D | 0.40668013 |
| 112 | EIF2AK2 | 0.39641047 |
| 113 | PLK1 | 0.38851623 |
| 114 | JAK3 | 0.38587223 |
| 115 | PDK3 | 0.38541635 |
| 116 | PDK4 | 0.38541635 |
| 117 | STK39 | 0.37675697 |
| 118 | NLK | 0.37578174 |
| 119 | TXK | 0.36969084 |
| 120 | ATR | 0.36886623 |
| 121 | AURKA | 0.36515381 |
| 122 | MAP3K4 | 0.35356097 |
| 123 | CDK3 | 0.34659488 |
| 124 | OXSR1 | 0.34237935 |
| 125 | MARK1 | 0.33845564 |
| 126 | IRAK2 | 0.33579933 |
| 127 | MAP3K3 | 0.33385534 |
| 128 | IGF1R | 0.33062599 |
| 129 | NEK2 | 0.32989125 |
| 130 | BTK | 0.32845046 |
| 131 | GRK1 | 0.31293315 |
| 132 | RPS6KB2 | 0.30473064 |
| 133 | CDK1 | 0.29978082 |
| 134 | CSNK1A1L | 0.29544438 |
| 135 | MST1R | 0.29139692 |
| 136 | PRKCI | 0.29103388 |
| 137 | CDK18 | 0.28642493 |
| 138 | SIK3 | 0.28496358 |
| 139 | TIE1 | 0.27914563 |
| 140 | PRKCB | 0.26816928 |
| 141 | PRKCG | 0.26779625 |
| 142 | CSNK1E | 0.26478588 |
| 143 | MAP3K8 | 0.26177417 |
| 144 | EPHA3 | 0.26132019 |
| 145 | SYK | 0.25889964 |
| 146 | FGFR2 | 0.25471250 |
| 147 | KDR | 0.24280002 |
| 148 | LATS1 | 0.22372644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 5.98899443 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.39801651 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.39323461 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.01515787 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.93358230 |
| 6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.79257319 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.61719704 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.61381604 |
| 9 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.60150754 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.59435468 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.52600751 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.31207066 |
| 13 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.20640730 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 1.93733777 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.90443102 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.74211460 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63640886 |
| 18 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.59541755 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54398690 |
| 20 | Phagosome_Homo sapiens_hsa04145 | 1.53402809 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51426076 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48842537 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 1.47207066 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.46000660 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.45425505 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.43657638 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.43496126 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.41751181 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.39547862 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25862644 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22723968 |
| 32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.21423454 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.20128405 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 1.16872806 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13709493 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.13488851 |
| 37 | Alcoholism_Homo sapiens_hsa05034 | 1.10944139 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10798786 |
| 39 | Cell cycle_Homo sapiens_hsa04110 | 1.07840043 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05212307 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.01964515 |
| 42 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.00923138 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.00812327 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99879066 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99654556 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97029269 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 0.95297106 |
| 48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.94210930 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93210378 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89903254 |
| 51 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.89669156 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88549248 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87854493 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 0.87772674 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87130556 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86998243 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85452924 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84572003 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82316106 |
| 60 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.79086449 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77858375 |
| 62 | Ribosome_Homo sapiens_hsa03010 | 0.77177495 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75152417 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75012929 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74642877 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.74357425 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73227945 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70903808 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69759776 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66886808 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64790697 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 0.64537954 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.62064081 |
| 74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61670903 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58180900 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57723525 |
| 77 | RNA transport_Homo sapiens_hsa03013 | 0.57111756 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53667922 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52852413 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51854141 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51757166 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49899440 |
| 83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49853980 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49644305 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.45049121 |
| 86 | RNA polymerase_Homo sapiens_hsa03020 | 0.44131777 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.40511916 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40209532 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39897523 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39550701 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39174036 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38460785 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37739016 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37148532 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36251033 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36056505 |
| 97 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.35154596 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34518723 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33822798 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33018291 |
| 101 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31857572 |
| 102 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31520788 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31405466 |
| 104 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.31377978 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31328358 |
| 106 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.30535794 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30367874 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28903138 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28465563 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27138617 |
| 111 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.25807616 |
| 112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25589327 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.25177608 |
| 114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25098221 |
| 115 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24901238 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23086592 |
| 117 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21236325 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.19923776 |
| 119 | Retinol metabolism_Homo sapiens_hsa00830 | 0.19504887 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.19336686 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18928596 |
| 122 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.18228421 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.17403676 |
| 124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.16516348 |
| 125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.14007176 |
| 126 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.11823575 |
| 127 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.10566140 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10514044 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.09678665 |
| 130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.09007490 |

